We experienced 3 cases of living renal transplantation in our department since its initiation in April 2015. All three patients made favorable recoveries. Generally, the introduction of renal transplantation requires a specified period of preparation time, not only to meet institutional criteria but also to cooperate with other departments or other related units (e. g., clinical laboratory or pharmacy) and to educate other healthcare professionals. We received support from a variety of departments and units in the hospital, and we were able to prepare for the introduction of living renal transplantation in the short time of only 4 months.

No abstract

We evaluated the efficacy of non-contrast magnetic resonance imaging (MRI)/transrectal ultrasound (TRUS) fusionguided transperineal biopsy for the detection of prostatic carcinoma. Methods: Between November 2013 and June 2015, eighty-three men, who presented to the Department of Urology with a clinically suspicious prostatic cancer, underwent non-contrast MRI/TRUS fusion biopsy (FB) (BioJet ® : D&K Technologies, Kanalweg, Germany) and 16-core systematic biopsy (SB). All biopsies were taken through a transperineal template. In 27 patients, the Gleason scores of biopsy specimens were compared to those of radical prostatectomy specimens. Results: The median patient age was 69 years (IQR 67-73) and the median Prostate Specific Antigen (PSA) level was 6.6 ng/ ml (IQR 5.2-8.9). Fifty-three patients were diagnosed with prostate cancer (PCa) (64%) by biopsy. The per-core cancer detection rate (CDR) was found to be higher for FB than for SB (32.5 vs 13.3%; p < 0.0001). Although not statistically significant, the CDR for clinically significant PCa was numerically higher for FB than for SB (65.1 vs 58.0%; p = 0.309). The Gleason scores of prostatectomy specimens were assessed to be higher than those of biopsy specimens in 44% of the cases in the FB group and in 37% of those in the SB group. Conclusion: Our study adds to the literature which supports the potential role of non-contrast MRI/TRUS fusion-guided transperineal biopsy in the detection of PCa, with a significantly higher per-core CDR compared with SB.